Product Description
Product Name: Sunitinib Malate Capsule
Strength: 50 mg
Form: Oral Capsule
Category: Antineoplastic / Tyrosine Kinase Inhibitor (TKI)
Indication: Advanced and Metastatic Cancers
Sunitinib Malate 50 mg Capsule is an oral targeted therapy classified as a multi-targeted receptor tyrosine kinase inhibitor (TKI). It is used for the treatment of various advanced and metastatic cancers by inhibiting pathways involved in tumor growth, angiogenesis, and cancer cell proliferation.
